ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,220.37
2.31%
S&P 500
5,484.80
0.13%
Dow Jones
39,182.98
0.14%
US Dollar vs Yen
160.5225
-0.06%
Brent Oil
85.055
0.69%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Cure Pharmaceutical Holding Corporation (PK) (CURR)

  7. Cure Pharmaceutical Holding Corporation (PK) (CURR) ニュース

CURR

Cure Pharmaceutical (PK) (CURR)

Cure Pharmaceutical Holding Corporation (PK)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:CURR
日付受信時刻ニュースソース見出しコード企業名
2024/05/3104 : 14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2024/05/1801 : 30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2024/05/1702 : 52Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2024/05/0804 : 36Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2024/05/0306 : 20Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2024/04/0201 : 15Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/11/1505 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/09/2005 : 29Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/08/2607 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/08/2210 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/08/2210 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/08/2210 : 48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/08/2210 : 47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/08/1505 : 32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/08/1202 : 28Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/07/2906 : 17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/07/2906 : 01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/05/2219 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/05/1605 : 56Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/04/2101 : 34Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/03/0907 : 12Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2023/01/1802 : 29Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2022/11/1507 : 25Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2022/09/1607 : 12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2022/09/1405 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2022/09/0219 : 08Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2022/08/2401 : 27Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2022/08/2307 : 30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2022/08/2307 : 29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
2022/08/2307 : 27Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CURRCure Pharmaceutical Holding Corporation (PK)
 Showing the most relevant articles for your search:USOTC:CURR

最近閲覧した銘柄

USOTC
ADDYY
Adidas (QX)
NYSE
NKE
Nike
AMEX
XLF
Financial Select Sector
NYSE
BAC
Bank of America
NASDAQ
TSLA
Tesla
NASDAQ
NVDA
NVIDIA
USOTC
BASFY
BASF (QX)
NYSE
MCD
McDonalds
USOTC
RHHBY
Roche (QX)
NASDAQ
GOOGL
Alphabet
NASDAQ
AAPL
Apple
CCOM
US30
US 30
NYSE
DIS
Walt Disney
FX
USDJPY
US Dollar vs Yen
NYSE
VZ
Verizon Communications
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有